Takeda’s Industry Symposium Webcasts
Debate 1: Use of continuous vs. fixed-duration therapy as treatment approaches in multiple myeloma
Debate 2: Use of triplet vs. doublet combination regimens for the treatment of relapsed/refractory multiple myeloma